QuadMedicine develops microneedle array patch (MAP) platforms that enhance skin immunity and streamline medication delivery for medical and pharmaceutical applications. Their technology improves patient compliance and accessibility by providing a less invasive and more efficient method for drug administration.
Funding
$19M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of drug delivery and skin immunity enhancement often involve invasive procedures and complex administration, leading to challenges in patient compliance and accessibility, particularly in remote or resource-limited settings. Traditional injections can cause discomfort, require trained personnel, and pose risks of infection, while topical treatments may have limited efficacy due to poor skin penetration.
Solution
QuadMedicine is developing microneedle array patch (MAP) platforms designed to enhance skin immunity and streamline medication delivery through a less invasive and more efficient method. These MAP platforms aim to improve patient compliance and accessibility by offering a user-friendly alternative to traditional injections and topical applications. The technology integrates formulation development, aseptic manufacturing, and analytical quality control to ensure product safety and efficacy. By maximizing usability and productivity, QuadMedicine's MAP platforms strive to realize health equity and improve healthcare outcomes for a broader population.
Target Audience
The primary target audience includes pharmaceutical companies seeking innovative drug delivery systems, healthcare providers aiming to improve patient outcomes, and individuals requiring convenient and less invasive methods for medication administration and skin immunity enhancement.
Features
- Microneedle array patch (MAP) technology for transdermal drug delivery
- Enhanced skin immunity through targeted delivery of immunomodulatory agents
- Formulation development expertise for optimal drug encapsulation and release
- Aseptic manufacturing processes to ensure product sterility and safety
- Analytical quality control measures to maintain product consistency and efficacy
- User-friendly design for easy self-administration, improving patient compliance